China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
1.700
+0.040 (2.41%)
At close: Dec 5, 2025, 4:00 PM EST
1.700
0.00 (0.00%)
After-hours: Dec 5, 2025, 8:00 PM EST
China Pharma Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 4.05 | 4.53 | 7.01 | 8.1 | 9.64 | 10.87 | |
| Revenue Growth (YoY) | -26.91% | -35.41% | -13.48% | -15.95% | -11.27% | -0.53% | |
| Cost of Revenue | 4.5 | 6.51 | 7.29 | 8.6 | 9.29 | 8.91 | |
| Gross Profit | -0.44 | -1.99 | -0.28 | -0.49 | 0.35 | 1.95 | |
| Selling, General & Admin | 2.67 | 2.31 | 2.25 | 2.96 | 3.15 | 4.04 | |
| Research & Development | -0.06 | 0.28 | 0.24 | 0.19 | 0.32 | 0.38 | |
| Operating Expenses | 2.64 | 2.6 | 2.47 | 3.06 | 3.21 | 4.53 | |
| Operating Income | -3.08 | -4.59 | -2.75 | -3.55 | -2.86 | -2.58 | |
| Interest Expense | -0.11 | -0.15 | -0.33 | -0.43 | -0.54 | -0.29 | |
| Interest & Investment Income | 0 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
| EBT Excluding Unusual Items | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | |
| Pretax Income | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | |
| Net Income | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | |
| Net Income to Common | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | |
| Shares Outstanding (Basic) | 3 | 2 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 3 | 2 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 135.14% | 416.13% | 221.82% | 13.96% | 5.75% | 0.10% | |
| EPS (Basic) | -1.00 | -2.71 | -9.10 | -37.79 | -36.85 | -32.86 | |
| EPS (Diluted) | -1.00 | -2.71 | -9.10 | -37.79 | -36.85 | -32.86 | |
| Free Cash Flow | 0.16 | -0.5 | -0.71 | -0.81 | -0.69 | -0.91 | |
| Free Cash Flow Per Share | 0.05 | -0.29 | -2.10 | -7.72 | -7.46 | -10.43 | |
| Gross Margin | -10.94% | -43.84% | -4.01% | -6.09% | 3.62% | 17.97% | |
| Operating Margin | -76.10% | -101.32% | -39.25% | -43.79% | -29.67% | -23.73% | |
| Profit Margin | -78.72% | -104.58% | -43.91% | -49.02% | -35.26% | -26.38% | |
| Free Cash Flow Margin | 3.86% | -11.15% | -10.14% | -10.01% | -7.13% | -8.37% | |
| EBITDA | -1.63 | -1.97 | 0 | -0.85 | 0.23 | 0.1 | |
| EBITDA Margin | -40.21% | -43.52% | 0.03% | -10.47% | 2.36% | 0.93% | |
| D&A For EBITDA | 1.45 | 2.62 | 2.75 | 2.7 | 3.09 | 2.68 | |
| EBIT | -3.08 | -4.59 | -2.75 | -3.55 | -2.86 | -2.58 | |
| EBIT Margin | -76.10% | -101.32% | -39.25% | -43.79% | -29.67% | -23.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.